Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

Analyst Ratings

Expert Ratings for Ally Financial

By Benzinga Insights

September 29, 12:00 PM

Analysts have provided the following ratings for Ally Financial (NYSE:ALLY) within the last quarter: Bullish Somewhat Bullish Indifferent…

ALLY

Madison Square Garden Sports’ Topline Climbs Amid Higher Ticket Sales, Yet Earnings Fall Short

By Anusuya Lahiri

May 2, 12:18 PM

Madison Square Garden Sports reports Q3 2024 revenue of $429.95M, above analyst estimate of $420.74M. Revenue up 12% YoY due to higher ticket, suite, F&B sales, and media fees.

MSGS

Analyst Ratings

Where Controladora Vuela Stands With Analysts

By Benzinga Insights

July 6, 11:08 AM

Within the last quarter, Controladora Vuela (NYSE:VLRS) has observed the following analyst ratings:

VLRS

Remember The Concorde? This Airline Is Bringing Back Supersonic Flight

By AJ Fabino

August 16, 7:07 PM

The Concorde was the first supersonic passenger commercial airplane. Built in the 1960s as part of a joint venture between the U.K. and France, the Concorde introduced a new and faster way to fly.

AAL

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Related Posts

Expert Ratings for Ally Financial

Madison Square Garden Sports’ Topline Climbs Amid Higher Ticket Sales, Yet Earnings Fall Short

Where Controladora Vuela Stands With Analysts

Remember The Concorde? This Airline Is Bringing Back Supersonic Flight